Skip to search formSkip to main contentSkip to account menu

BB-10153

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Plasminogen

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial
Background: Currently available fibrinolytic agents are limited by their ability to restore normal blood flow in only half of… 
2005
2005
Thrombolytic activity of BB‐10153, a thrombin‐activatable plasminogen
Summary.  Background: BB‐10153 is an engineered variant of human plasminogen, modified to be activated to plasmin by thrombin… 
2005
2005
Pharmacokinetics and pharmacodynamics of BB‐10153 1 , a thrombin‐activatable plasminogen, in healthy volunteers
Summary.  Background: BB‐10153 is an engineered variant of human plasminogen that is activated to plasmin by thrombin. Thrombus… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)